Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2021 | HSCT for the trainee

Hélène Schoemans • 14 Mar 2021
EBMT 2021
General

Hélène Schoemans, MD, University of Leuven, Leuven, Belgium, provides a summary of her EBMT 2021 talk on hematopoietic stem-cell transplantation (HSCT) for the trainee, with the key take-home message being collaboration. This interview took place during the 47th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) 2021.

Disclosures

Dr Hélène Schoemans, MD, has participated in advisory boards for Incyte, Janssen, and Novartis; has received speaker’s fees from Novartis, Incyte, Jazz Pharmaceuticals, the Belgian Hematological Society (BHS) and Takeda; has received travel grants from AbbVie, Celgene, CIBMTR, EBMT, Gilead and Incyte, has received research funding from Novartis and the BHS; and has volunteered for the BHS, the CIBMTR, EBMT, and EUPATI.

More from Hélène Schoemans

1:12
Patient-reported outcomes in HSCT
Hélène Schoemans • 14 Mar 2021
1:37
The importance of patient engagement
Hélène Schoemans • 14 Mar 2021

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals